Treatment options for benign prostatic hyperplasia

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.3, Iss.1, 1998-06, pp. : 225-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment options for benign prostatic hyperplasia reviewed

Inpharma, Vol. 1, Iss. 1313, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Combination Therapy for the Pharmacological Management of Benign Prostatic Hyperplasia: Rationale and Treatment Options

By Sandhu Jaspreet S.

Drugs & Aging, Vol. 22, Iss. 11, 2005-01 ,pp. : 901-912

Adis International

Access to resources Recommend Favorite

Dutasteride for the treatment of benign prostatic hyperplasia

By Wu Christopher Kapoor Anil

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1399-1408

Informa Healthcare

Access to resources Recommend Favorite

NX 1207 is promising for the treatment of benign prostatic hyperplasia

Inpharma, Vol. 1, Iss. 1617, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Treatment of Benign Prostatic Hyperplasia in Patients with Cardiovascular Disease

By Santillo Vincent M. Lowe Franklin C.

Drugs & Aging, Vol. 23, Iss. 10, 2006-01 ,pp. : 795-805

Adis International

Access to resources Recommend Favorite